SUMMARY This report describes a patient without evident underlying disease, in whom an acquired von Willebrand's syndrome was discovered before surgery. Coagulation abnormalities included a borderline bleeding time, a low retention of platelets on glass beads, decreased levels of factor VIII procoagulant activity (VIII.), factor VIII-related antigen (VIfIAg), and ristocetin-induced agglutination cofactor (VIfIv,,). After cryoprecipitate infusion the patient did not have the expected rise and there was no secondary increment in Vmffi. The patient was treated with prednisone for three weeks without significant improvement in the laboratory findings. Spontaneous resolution was observed long after this therapy. The haemostatic abnormalities were attributable to the presence of an inhibitor directed against VIIIvWF. This inhibitor was found in the IgM fraction. Its autoimmune nature is probable although we failed to demonstrate any inhibitory effect of Fab obtained from the patient's purified IgM. Despite the lack of inhibitory effect against VIIIAHF and VIIIAg, the low levels of all three activities of the factor VIII complex could be explained by the short half-life of immune complexes between factor VIII and the inhibitor.
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Classical von Willebrand's disease is a congenital bleeding disorder with an autosomal dominant inheritance characterised by a long bleeding time, decreased platelet retention on glass beads, decreased factor VIII procoagulant activity, decreased factor VIII antigen, and decreased ristocetin-induced agglutination cofactor. This pattern defines typical von Willebrand's disease although various genetic variants have been reported (Hoyer, 1976) . In recent years some patients with an acquired form of the disease have been described. Most Borchgrevink (1960) .
In-vivo platelet retention was measured during the Ivy bleeding time by the Borchgrevink (1960) technique.
Glass-bead platelet retention was measured according to a modified technique of Hellem (1970) using commercial packed glass bead columns with a blood flow of 5 ml/30 s (Mascia Brunelli, Milan) .
Prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen, clot retraction, residual serum prothrombin assay, and factors II, V, and VII + X assays (one-stage method) were performed according to Josso and Prou-Wartelle (1972) .
Factor VIII and factor IX procoagulant activities were measured by a one-stage procedure using haemophilic plasmas as substrate.
Factor VIIIAg was measured by electroimmunodiffusion according to Laurell (1966) using a specific rabbit antihuman factor VIII antiserum (Behringwerke). VIIIAg was also studied by crossed immunoelectrophoresis on cryoprecipitates from normal and patient's plasmas. RISTOCETIN-INDUCED AGGLUTINATION COFACTOR (VIIIvwF) This was measured according to Weiss et al. (1973) using fresh washed normal platelets and a final ristocetin concentration of 1-5 mg/ml. In an attempt to demonstrate an inhibitory activity in vivo, we studied the patient's response after cryoprecipitate infusion (Fig. 1) No inhibitory activity against VIIIVHF was found in vitro even after 2 hours' incubation at 370C. An attempt to dissociate antigen-antibody complexes by heating the patient's plasma at 560C did not reveal any inhibitory effect. Patient's plasma did not interfere with the precipitation of normal VIIIAg by heterologous antibodies. It was difficult to decide on any inhibitory activity against VIIIVWF: in the mixture of normal and patient's plasmas the initial velocity is not reduced but the maximum change in light transmission is slightly decreased compared with normal plasma and buffer (Fig 2a) .
INHIBITORY EFFECT OF PATIENT'S PURIFIED
IMMUNOGLOBULIN FRACTIONS (Fig. 2b, c) Fractions of patient's serum containing pure IgG (including the monoclonal protein) or IgA did not inhibit either ristocetin-induced agglutination of normal washed platelets or VIIIAHF. Patient's IgM, however, had an inhibitory activity against VIIIVWF but not against VIIIAHF or VIIIAg. When the Fc (0-0625 to 1 mg/ml final) and Fab (0 075 to 1-125 mg/ml final) fragments were purified The patient reported here had the laboratory features of von Willebrand's syndrome (Hoyer, 1976) . Its acquired nature was suspected because of the late onset of the disease and the absence of a familial bleeding history. An abnormal response to cryoprecipitate infusion suggested the presence of an inhibitor of the factor VIII complex, which was demonstrated by in-vitro studies. This inhibitor was selectively directed against VIIIVwF. Its probable autoimmune nature was supported by the presence of the inhibitory activity in the immunoglobulin fraction, its association with other immunoglobulin abnormalities, and the spontaneous recovery.
Since 1968, some 16 cases of acquired von Willebrand's disease have been reported. Some cases occurred in association with systemic lupus erythematosus (Simone et al., 1968; Ingram et al., 1971; Poole-Wilson, 1972; Ingram et al., 1973; Leone et al., 1974; Gazengel et al., 1978) while others were described with lymphoproliferative disorders (Handin et al., 1976; Wautier et al., 1976; Joist et al., 1978 ) and a few with monoclonal immunoglobulins without evidence of multiple myeloma (Ingram et al., 1971; Mant et al., 1973; Meyer et al., 1974; Rosborough and Swaim, 1978) . One case occurred after pesticide ingestion (Veltkamp et al., 1970 An abnormal response to factor VIII concentrate infusion was described in most of the cases (Mant et al., 1973; Handin et al., 1976; Stableforth et al., 1976; Rosborough and Swaim, 1978; Gazengel et al., 1978) . Recovery of injected factor VIIIAHF was generally poor and without the sustained rise usually observed in patients with congenital von Willebrand's disease (Chediak et al., 1977) . Of the cases in which in-vitro evidence of an inhibitor was found, three had inhibitory activity against ristocetin cofactor alone (Leone et al., 1974; Handin et al., 1976; Wautier et al., 1976) , while in one case inhibitor was also directed against factor VIIIAHF (Stableforth et al., 1976) and in another against factor VIIIAg (Gazengel et al., 1978) . In those cases in which immunoglobulins were purified, the inhibitor was found either in the IgG fraction (Handin et al., 1976; Gazengel et al., 1978) or in the IgA fraction (Wautier et al., 1976) (Moore et al., 1978) . Despite the absence of inhibitory activity in Fab fragments other findings strongly suggest that the inhibitor is autoimmune in nature.
Much evidence suggests that VIIIVWF activity is closely related to the binding sites of xenogeneic antibodies. The inhibitory activity of our patient's antibody could be demonstrated only against VIIIVWF and not against other attributes of the factor VIII complex. It is interesting that, in contrast to the case reported by Gazengel et al. (1978) , the binding of the 1gM inhibitor to the VWF site did not affect the recognition of the molecule by xenogeneic antibodies. The concomitant reduction in VIIIAHF and VIIIAg in patient's plasma could be explained by the short half-life of immune complexes formed between the VIIIVWF antigenic site and the autoantibody, resulting in the removal of the whole factor VIII complex.
